Fitness and Health
GLP-1 Muscle Loss Supplements: Do Creatine, HMB, Urolithin A, or SARMs Protect Your Muscle on Ozempic or Zepbound?
Can a supplement stop you from losing muscle on Ozempic, Wegovy, Zepbound, or reta? Not on its own. As of October 2026, no supplement has been proven in a real trial to protect muscle in people taking these drugs. Protein comes closest, and creatine is a cheap, safe add on if you lift. Most of the rest is marketing. The only things shown to save muscle during GLP-1 weight loss are lifting, enough protein, and a few new prescription drugs that are still in trials. Meanwhile, some people are skipping the wait and buying black market SARMs, which is where the real damage happens.
Why this matters for your looks
Losing fat is the point, but losing muscle at the same time is how people end up smaller yet softer, with flat shoulders, thin arms, and the "skinny fat" look. In trials, people on semaglutide alone lost lean mass too. In one 2026 trial, about 28% of the weight lost on semaglutide alone was not fat. In a 2026 study of patients outside of trials, fat free mass made up about 30% of the weight lost at 6 months and about 25% at 12 months.
Two things are worth knowing before you panic. "Lean mass" on a scan includes water, organs, and connective tissue, not just muscle. And some lean loss happens with any big weight loss, including diet alone. The real question is whether you keep your strength and shape. That part is mostly in your hands.
The supplement boom around these drugs
On October 20, 2026, Reuters reported that nearly half of GLP-1 users started new vitamins or supplements after starting the drugs, based on a Nutrition Business Journal survey. Protein, fiber, and probiotics were the most popular. A big vitamin chain said its fiber and creatine sales grew by double digits this year, and it named GLP-1 users as a reason. One nurse who promotes products online said her supplement routine costs $200 to $300 a month.
None of these products need FDA approval before they are sold. Many are pushed by influencers who earn a cut of each sale, which the Reuters story pointed out about the people it profiled.
Supplement by supplement: what the evidence says
- Protein powder or shakes: the one that matters. A June 2026 review of the research in Metabolites called protein the most defensible supplement for GLP-1 users, because most people simply do not eat enough. In one study of current users, only 43% hit even the low end of the protein target (1.2 grams per kilogram of body weight a day), the average was about 77 grams a day, and about 40% of daily protein came at dinner. If shakes are what you can keep down, they count. Spreading protein across the day beats one big evening meal.
- Creatine: cheap, safe, unproven here. Creatine helps people who lift build muscle and strength, with the clearest gains when paired with training. But it has never been tested in a trial of people on GLP-1 drugs. A paper in Clinical Nutrition (online September 21, 2026) proposed it as a "biologically plausible" add on and said plainly that no trial has tested it. Worth knowing: the lead author disclosed patents on creatine products, a seat on a creatine maker's advisory board, and a company that makes creatine foods.
- HMB: small effects in older adults. A 2025 analysis of 21 trials in adults over 50 found modest gains in muscle and strength, larger with exercise. There is no trial in GLP-1 users, and an expert position paper calls the effects modest.
- Urolithin A: thin evidence. A July 2026 review found only 5 small trials with 236 people total. The one outcome that could be pooled, a 6 minute walk test, was not a clear win, and the authors rated the evidence low. Lean mass did not change in the trial that measured it. A trial in adults with obesity is under way, with completion listed for February 2027.
- Collagen, electrolytes, probiotics, omega 3: Not muscle builders. A 2025 joint advisory from four US obesity and nutrition groups did not list collagen or electrolyte mixes as priorities, and a 2025 overview of 33 reviews found omega 3 cannot be recommended for keeping lean mass.
New research (September and October 2026)
The real action is in prescription drugs, not the supplement aisle.
- Trevogrumab (Regeneron), October 1, 2026. In the phase 2 COURAGE trial, people on semaglutide alone lost 7.3% of their lean mass in a year. Adding the higher of two low doses of trevogrumab cut that to 4.2%, and MRI scans showed it saved almost 70% of the thigh muscle that would have been lost. Side effects were about the same as placebo. The results are in press at The Lancet. It is not approved.
- Enobosarm (Veru), September 9, 2026. This is a SARM, the same drug sold online as "ostarine." In a 16 week trial of 239 people over 60 starting semaglutide, the company says the low dose kept lean mass and that weight lost was all fat. It also says 44% of people on semaglutide alone lost more than 10% of their stair climbing power, and the drug cut that by up to 60%. Liver enzymes rose in one person on the low dose and in more people on the higher dose. These are company statements. Bigger results are due in early 2027.
- Bimagrumab (Lilly), published March 2026. In the BELIEVE trial, bimagrumab plus semaglutide led to 22.1% weight loss, with 92.8% of it fat. Bimagrumab alone added 2.5% lean mass. Side effects included muscle spasms, diarrhea, and acne. Lilly paid for the study.
What people who tried it say
These are real posts from GLP-1 users in October 2026, summarized.
- The worried beginner. One person down 50 lb said they felt great but were "starting to feel it." They lift twice a week and take a dance class, and were thinking about calcium and creatine out of fear of losing muscle and bone.
- The bad advice. One person on Zepbound who lifts 3 times a week, eats about 100 grams of protein, and takes creatine said their doctor told them to "just stop eating," that "you'll lose muscle but you'll gain it back later," and that "the hair loss is fine too." They called it awful advice. Most replies agreed. Muscle lost while starving does not come back on its own.
- Lighter but softer. A 31 year old man on black market reta went from 88 kg to 79 kg in about 10 weeks. His abs started to show, but he said he still looked "skinny fat," had dizziness from low blood pressure, felt his recovery slip, and gassed out much faster when sparring.
- Doing everything, still weak. A 48 year old woman on reta who does CrossFit 3 to 4 days a week and takes creatine daily said she feels "weaker than I should" and stays sore for 3 days after hard workouts.
- The before and after that is not what it looks like. One person who went from about 310 to 235 lb in 16 months while lifting 4 to 5 days a week and hitting a 375 lb bench was upfront that they also used testosterone, tirzepatide, reta, and other drugs. Many dramatic "kept my muscle" photos online have hormones behind them, not a supplement.
The edgy trend: black market SARMs with GLP-1s
After the enobosarm news, some users started buying "ostarine" online to stack with their GLP-1. One August 2026 post called it maybe "the biggest breakthrough in weight loss" and said the writer had "already ordered it online." In October, a man said his first SARM cycle while on reta made him leaner and stronger, but his blood tests then showed his testosterone had "completely tanked" to the very bottom of the range, with low sex drive.
Here is what goes wrong. SARMs mimic testosterone, so your body cuts its own supply. The FDA lists liver injury and acute liver failure, heart attack and stroke risk, sexual problems, testicle shrinkage, and infertility among reported harms, and says it keeps getting reports. And you often do not get what you paid for: when researchers tested 44 products sold online as SARMs, only 52% contained a SARM at all, 39% contained a different unapproved drug, 9% had no active drug, and 59% had amounts that did not match the label. The trial drug was given at a low dose to older adults under close watch with blood tests. Forum stacks use higher amounts, multiple drugs, and no checks. That is not the same thing. We do not give doses or sources.
Lesser-known tips
- Track strength, not the scale. If your lifts hold steady or rise while weight drops, you are keeping muscle. The trial companies now measure stair climbing power for the same reason.
- Creatine adds water weight. Expect the scale to bump up a little when you start. It also raises creatinine on blood tests, which can look like a kidney problem if whoever reads your labs does not know you take it.
- Eat protein first. When you can only eat a little, eat the protein part of the meal before anything else.
- Fast loss costs more. In the trevogrumab trial, most lean loss happened in the first six months, when weight came off fastest.
- "GLP-1 friendly" is a marketing phrase. As of September 2026, no US or EU regulator has defined it.
Positives and negatives
Positives: Protein and creatine are cheap and well studied in general. Lifting works. Real muscle saving drugs may arrive in a few years.
Negatives: No supplement is proven in GLP-1 users. Many products are sold by people paid to sell them. Black market SARMs can crash your hormones, hurt your liver, and may not even contain what the label says.
Bottom line
There is no magic pill for GLP-1 muscle loss in 2026. Lift two to three times a week, hit your protein, and add creatine if you want a cheap extra. Skip the $200 a month stacks, and skip SARMs entirely. If you want to know whether you look leaner or just smaller in your photos, The Face They See lets people of the opposite gender rank your photos for free.
Related guides
Sources
- https://www.medscape.com/s/viewarticle/weight-loss-drug-users-turn-dietary-supplements-doctors-2026a10013du
- https://www.medicaldaily.com/glp-1-users-supplements-fda-oversight-480209
- https://doi.org/10.1016/j.clnu.2026.106805
- https://www.mdpi.com/2218-1989/16/6/364
- https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1834344/full
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12685510/
- https://newsroom.regeneron.com/news-releases/news-release-details/phase-2-courage-trial-confirms-trevogrumab-prevents-lean-mass/
- https://www.pbrc.edu/news/media/2026/semaglutide_and_bimagrumab.aspx
- https://in.investing.com/news/stock-market-news/veru-at-12th-annual-cantor-fitzgerald-global-healthcare-conference-muscle-focus-93CH-5587497
- https://pubmed.ncbi.nlm.nih.gov/29183075/
- https://www.fda.gov/consumers/consumer-updates/fda-warns-use-selective-androgen-receptor-modulators-sarms-among-teens-young-adults
- https://www.newfoodmagazine.com/glp-1-friendly-has-no-regulatory-definition-and-manufacturers-are-shipping-it-anyway/2136418.article
- https://clinicaltrials.gov/study/NCT07377136
- https://www.reddit.com/r/Semaglutide/comments/1wz3sgt/down_50_lbs_but_very_concerned_about_muscle_loss/
- https://www.reddit.com/r/InsulinResistance/comments/1xck6m6/i_feel_weird_about_my_doctors_recommendation/
- https://www.reddit.com/r/Biohacking/comments/1x5ma47/new_to_peptides_2_months_on_retatrutide_down_9kg/
- https://www.reddit.com/r/BodyHackGuide/comments/1xg44kh/insights_for_semibeginner/
- https://www.reddit.com/r/SARMsTalk/comments/1xcvfds/first_sarms_cycle_worked_well_but_tanked/
- https://www.reddit.com/r/GLP1ResearchTalk/comments/1vrci5a/novo_nordiskbacked_glp1_addon_preserved_99_of/
- https://www.reddit.com/r/Biohacking/comments/1xfkdra/310_to_235lb_in_about_16_months/